Table 4:

Symptoms by route of exposure*

VariableRoute; no. (%) of people
Dermal†
n = 22		Ingestion†
n = 122		Inhalation†
n = 28		Total‡
n = 186
Symptoms present
Yes12 (54.5)38 (31.1)25 (89.3)87 (46.8)
No7 (31.8)60 (49.2)2 (7.1)70 (37.6)
Not recorded3 (13.6)24 (19.7)1 (3.6)29 (15.6)
Symptoms§
Local
 Dermal4 (18.2)0 (0.0)1 (3.6)5 (2.7)
 Oral/pharyngeal0 (0.0)7 (5.7)1 (3.6)9 (4.8)
 Respiratory0 (0.0)1 (0.8)1 (3.6)3 (1.6)
 Ocular0 (0.0)0 (0.0)0 (0.0)11 (5.9)
 Vaginal0 (0.0)0 (0.0)0 (0.0)1 (0.5)
Systemic
 Not typical for nicotine exposure4 (18.2)19 (15.6)11 (39.3)45 (24.2)
 Typical for low nicotine exposure8 (36.4)18 (14.8)15 (53.6)42 (22.6)
 Typical for high nicotine exposure0 (0.0)2 (1.6)0 (0.0)2 (1.1)

  • ↵* Excludes people with coingestions as these substances may have contributed to symptomatology.

  • ↵† Excludes people with multiple routes of exposure.

  • ↵‡ Includes people with nasal, ocular and vaginal exposures as well as multiple routes of exposure.

  • ↵§ Some people experienced multiple symptoms.